Quarterly Financial Information (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2017

Quarterly Financial Information Disclosure [Abstract]

Schedule of unaudited quarterly information

These operating results are not necessarily indicative of results for any future period (in thousands, except per share data):

	Year Ended December 31, 2017
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Total net revenues	$	—		$	2		$	1		$	568		(1)
Gross profit(2)	—			—			—			551
Net loss	(16,028		)	(20,745		)	(23,360		)	(29,357		)
Net loss per share, basic and diluted	(0.72		)	(0.93		)	(1.04		)	(1.27		)

	Year Ended December 31, 2016
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Total net revenues	$	175		$	222		$	138		$	37
Gross profit	—			—			—			—
Net loss	(13,828		)	(16,876		)	(14,394		)	(14,960		)
Net loss per share, basic and diluted	(0.65		)	(0.78		)	(0.66		)	(0.68		)

(1) In the fourth quarter of 2017 the Company commenced commercial sales of GOCOVRI.

(2) Gross profit is computed by subtracting cost of product sales from product sales, net.